STAT Plus: Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders
ADOBE
Pear Therapeutics is licensing voice biomarkers to improve treatment for illnesses ranging from Alzheimer’s to insomnia and substance use disorder.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario